Clinical Trial: Retlirafusp alfa combined with apatinib and short-course neoadjuvant chemoradiotherapy for resectable locally advanced rectal cancer: a single-arm, prospective, multicenter clinical study (China)

Posted On: 2026-08-24

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retlirafusp alfa combined with apatinib and short-course neoadjuvant chemoradiotherapy for resectable locally advanced rectal cancer: a single-arm, prospective, multicenter clinical study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130635

Registration Time: 2026/08/22

Type: Interventional study

Primary Sponsor: Quanzhou First Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338350

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Retlirafusp alfa combined with apatinib and short-course neoadjuvant chemoradiotherapy for resectable locally advanced rectal cancer: a single-arm, prospective, multicenter clinical study (China)